Onyx Pharmaceuticals Inc said on Sunday it is weighing a sale of the company, after rejecting a roughly $10 billion takeover offer from larger rival Amgen Inc as too low.
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment